Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (41-50 of 190) with videos related to

Pageof 19
Sort By:
Oncotarget|September 9, 2017
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Sabrina Lagniau, Kevin Lamote, Jan P van Meerbeeck, et al.
Frontiers in Oncology|February 6, 2023
Editorial: Imaging assessment of response to immunotherapyMariaelena Occhipinti, Andrea R Filippi, Sean Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
Pharmacoeconomics|November 10, 2005
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNiels Neymark, Pilar Lianes, Egbert F Smit, et al.
Critical Reviews in Oncology/Hematology|May 15, 2010
Malignant pleural mesothelioma: the standard of care and challenges for future managementJan P van Meerbeeck, Arnaud Scherpereel, Veerle F Surmont, et al.
Cancers|January 8, 2023
A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in BelgiumPaloma Diab Garcia, Annemiek Snoeckx, Jan P Van Meerbeeck, et al.
Lancet (London, England)|May 14, 2011
Small-cell lung cancerJan P van Meerbeeck, Dean A Fennell, Dirk K M De Ruysscher
Lung Cancer (Amsterdam, Netherlands)|July 12, 2015
Second line therapy in malignant pleural mesothelioma: A systematic reviewWieneke A Buikhuisen, Birgitta I Hiddinga, Paul Baas, et al.
Cancer Treatment Reviews|October 5, 2015
Targeting immune checkpoints: New opportunity for mesothelioma treatment?Elly Marcq, Patrick Pauwels, Jan P van Meerbeeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?Frank J Lagerwaard, Suresh Senan, Jan P van Meerbeeck, et al.
Pageof 19

Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
Oncotarget|September 9, 2017
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Sabrina Lagniau, Kevin Lamote, Jan P van Meerbeeck, et al.
Frontiers in Oncology|February 6, 2023
Editorial: Imaging assessment of response to immunotherapyMariaelena Occhipinti, Andrea R Filippi, Sean Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
Pharmacoeconomics|November 10, 2005
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancerNiels Neymark, Pilar Lianes, Egbert F Smit, et al.
Critical Reviews in Oncology/Hematology|May 15, 2010
Malignant pleural mesothelioma: the standard of care and challenges for future managementJan P van Meerbeeck, Arnaud Scherpereel, Veerle F Surmont, et al.
Cancers|January 8, 2023
A Cross-Sectional Study on the Acceptability of Implementing a Lung Cancer Screening Program in BelgiumPaloma Diab Garcia, Annemiek Snoeckx, Jan P Van Meerbeeck, et al.
Lancet (London, England)|May 14, 2011
Small-cell lung cancerJan P van Meerbeeck, Dean A Fennell, Dirk K M De Ruysscher
Lung Cancer (Amsterdam, Netherlands)|July 12, 2015
Second line therapy in malignant pleural mesothelioma: A systematic reviewWieneke A Buikhuisen, Birgitta I Hiddinga, Paul Baas, et al.
Cancer Treatment Reviews|October 5, 2015
Targeting immune checkpoints: New opportunity for mesothelioma treatment?Elly Marcq, Patrick Pauwels, Jan P van Meerbeeck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?Frank J Lagerwaard, Suresh Senan, Jan P van Meerbeeck, et al.
Pageof 19